LCN2 and hepatocellular carcinoma: Next, we identified that LCN2 mRNA and protein expression was decreased following the administration of two AKT inhibitors (LY294002 and MK‐2206) in shNC HCC cells and was upregulated following the administration of an AKT activator (SC79) (Figure 4G,H; Figure S4H,I, Supporting Information).